Acute Kidney Injury: Current Perspectives

References

• . Waikar SS, Liu KD, Chertow GM. The incidence and prognostic significance of acute kidney injury. Curr Opin Nephrol Hypertens. 2007;16(3):227–236
   PubMed Web of Science ®Google Scholar
• . Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370
   PubMed Web of Science ®Google Scholar
• . Mehta RL, Kellum JA, Shah SV, . Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31
   PubMed Web of Science ®Google Scholar
• . Bagshaw SM, George C, Bellomo R. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2008;23(5):1569–1574
   PubMed Web of Science ®Google Scholar
• . Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM. The outcome of acute renal failure in the intensive care unit according to RIFLE: model application, sensitivity, and predictability. Am J Kidney Dis. 2005;46(6):1038–1048
   PubMed Web of Science ®Google Scholar
• . Ali T, Khan I, Simpson W, . Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18(4):1292–1298
   PubMed Web of Science ®Google Scholar
• . Chen YC, Jenq CC, Tian YC, . Rifle classification for predicting in-hospital mortality in critically ill sepsis patients. Shock. 2009;31(2):139–145
   PubMed Web of Science ®Google Scholar
• . Kellum JA. Defining and classifying AKI: one set of criteria. Nephrol Dial Transplant. 2008;23(5):1471–1472
   PubMed Web of Science ®Google Scholar
• . Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol. 2000;278(1):F1–F12
   Web of Science ®Google Scholar
• . Sheridan AM, Bonventre JV. Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens. 2000;9(4):427–434
   PubMed Web of Science ®Google Scholar
• . Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357(8):797–805
   PubMed Web of Science ®Google Scholar
• . Rosen S, Heyman SN. Difficulties in understanding human “acute tubular necrosis”: limited data and flawed animal models. Kidney Int. 2001;60(4):1220–1224
   PubMed Web of Science ®Google Scholar
• . Thurau K, Boylan JW. Acute renal success. The unexpected logic of oliguria in acute renal failure. Am J Med. 1976;61(3):308–315
   PubMed Web of Science ®Google Scholar
• . Rosen S, Stillman IE. Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol. 2008;19(5):871–875
   PubMed Web of Science ®Google Scholar
• . Brezis M, Rosen S. Hypoxia of the renal medulla–its implications for disease. N Engl J Med. 1995;332(10):647–655
   PubMed Web of Science ®Google Scholar
• . Rosenberger C, Rosen S, Shina A, . Hypoxia-inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int. 2006;70(1):60–70
   PubMed Web of Science ®Google Scholar
• . Rosenberger C, Rosen S, Heyman SN. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357(21):2204–2205
   PubMed Web of Science ®Google Scholar
• . Dear JW, Yasuda H, Hu X, . Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis. Kidney Int. 2006;69(5):832–836
   PubMed Web of Science ®Google Scholar
• . Langenberg C, Wan L, Egi M, May CN, Bellomo R. Renal blood flow in experimental septic acute renal failure. Kidney Int. 2006;69(11):1996–2002
   PubMed Web of Science ®Google Scholar
• . Feltes CM, Van Eyk J, Rabb H. Distant-organ changes after acute kidney injury. Nephron Physiol. 2008;109(4):80–84
   Google Scholar
• . Waikar SS, Bonventre JV. Biomarkers for the diagnosis of acute kidney injury. Curr Opin Nephrol Hypertens. 2007;16(6):557–564
   PubMed Web of Science ®Google Scholar
• . Parikh CRJani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;43(3):405–414
   PubMed Web of Science ®Google Scholar
• . Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16(10):3046–3052
   PubMed Web of Science ®Google Scholar
• . Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73(9):1008–1016
   PubMed Web of Science ®Google Scholar
• . Mishra J, Dent C, Tarabishi R, . Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–1238
   PubMed Web of Science ®Google Scholar
• . Parikh CR, Jani A, Mishra J, . Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6(7):1639–1645
   PubMed Web of Science ®Google Scholar
• . Wagener G, Jan M, Kim M, . Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006;105(3):485–491
   PubMed Web of Science ®Google Scholar
• . Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89–94
   PubMedGoogle Scholar
• . Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre J.V. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237–244
   PubMed Web of Science ®Google Scholar
• . Liangos O, Perianayagam MC, Vaidya VS, . Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007;18(3):904–912
   PubMed Web of Science ®Google Scholar
• . Han WK, Waikar SS, Johnson A, . Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73(7):863–869
   PubMed Web of Science ®Google Scholar
• . Koyner JL, Bennett MR, Worcester EM, . Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74(8):1059–1069
   PubMed Web of Science ®Google Scholar
• . Bartholomew BA, Harjai KJ, Dukkipati S, . Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93(12): 1515–1519
   PubMed Web of Science ®Google Scholar
• . McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51(15):1419–1428
   PubMed Web of Science ®Google Scholar
• . Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936
   PubMed Web of Science ®Google Scholar
• . From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc. 2008;83(10):1095–1100
   PubMed Web of Science ®Google Scholar
• . Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275(19):1489–1494
   PubMed Web of Science ®Google Scholar
• . Scanlon PJ, Faxon DP, Audet AM, . ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33(6):1756–1824
   PubMed Web of Science ®Google Scholar
• . Efstratiadis G, Pateinakis P, Tambakoudis G, Pantzaki A, Economidou P, Memmos D. Contrast media-induced nephropathy: case report and review of the literature focusing on pathogenesis. Hippokratia. 2008;12(2):87–93
   PubMed Web of Science ®Google Scholar
• . Solomon R. Radiocontrast-induced nephropathy. Semin Nephrol. 1998;18(5):551–557
   PubMed Web of Science ®Google Scholar
• . Kolonko A, Kokot F, Wiecek A. Contrast-associated nephropathy–old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant. 1998;13(3):803–806
   PubMed Web of Science ®Google Scholar
• . Rudnick MR, Goldfarb S, Wexler L, . Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995;47(1):254–261
   PubMed Web of Science ®Google Scholar
• . ten Dam MA, Wetzels JF. Toxicity of contrast media: an update. Neth J Med. 2008;66(10):416–422
   PubMed Web of Science ®Google Scholar
• . Larson TS, Hudson K, Mertz JI, Romero JC, Knox FG. Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. J Lab Clin Med. 1983;101(3):385–391
   PubMed Web of Science ®Google Scholar
• . Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int. 1992;41(4):1008–1015
   PubMed Web of Science ®Google Scholar
• . Eisenberg RL, Bank WO, Hedgock MW. Renal failure after major angiography can be avoided with hydration. AJR Am J Roentgenol. 1981;136(5):859–861
   PubMed Web of Science ®Google Scholar
• . Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol. 2008;3(1):273–280
   PubMed Web of Science ®Google Scholar
• . Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331(21):1416–1420
   PubMed Web of Science ®Google Scholar
• . Krasuski RA, Beard BM, Geoghagan JD, Thompson CM, Guidera SA. Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. J Invasive Cardiol. 2003;15(12):699–702
   PubMedGoogle Scholar
• . Bader BD, Berger ED, Heede MB, . What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol. 2004;62(1):1–7
   PubMed Web of Science ®Google Scholar
• . Dussol B, Morange S, Loundoun A, Auquier P, Berland Y. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant. 2006;21(8):2120–2126
   PubMed Web of Science ®Google Scholar
• . Merten GJ, Burgess WP, Gray LV, . Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291(19):2328–2334
   PubMed Web of Science ®Google Scholar
• . Briguori C, Airoldi F, D'Andrea D, . Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115(10):1211–1217
   PubMed Web of Science ®Google Scholar
• . Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol. 1990;258(1 pt 2):F115–F120
   Google Scholar
• . Katholi RE, Woods WT Jr, Taylor GJ, . Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32(1):64–71
   PubMed Web of Science ®Google Scholar
• . Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180–184
   PubMed Web of Science ®Google Scholar
• . Briguori C, Colombo A, Violante A, . Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J. 2004;25(3):206–211
   PubMed Web of Science ®Google Scholar
• . Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65(4):1366–1374
   PubMed Web of Science ®Google Scholar
• . Nallamothu BK, Shojania KG, Saint S, . Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med. 2004;117(12):938–947
   PubMed Web of Science ®Google Scholar
• . Deray G. Dialysis and iodinated contrast media. Kidney Int Suppl. 2006(100):S25–S29
   Google Scholar
• . Marenzi G, Marana I, Lauri G, . The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349(14):1333–1340
   PubMed Web of Science ®Google Scholar
• . Lee PT, Chou KJ, Liu CP, . Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol. 2007;50(11):1015–1020
   PubMed Web of Science ®Google Scholar
• . Cruz DN, Perazella MA, Bellomo R, . Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Kidney Dis. 2006;48(3):361–371
   PubMed Web of Science ®Google Scholar
• . Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236–249
   PubMed Web of Science ®Google Scholar
• . Heyman SN, Brezis M, Greenfeld Z, Rosen S. Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis. 1989;14(5):377–385
   PubMed Web of Science ®Google Scholar
• . Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005;31(1):79–85
   PubMed Web of Science ®Google Scholar
• . Ludens JH, Hook JB, Brody MJ, Williamson HE. Enhancement of renal blood flow by furosemide. J Pharmacol Exp Ther. 1968;163(2):456–460
   PubMed Web of Science ®Google Scholar
• . Anderson RJ, Linas SL, Berns AS, . Nonoliguric acute renal failure. N Engl J Med. 1977;296(20):1134–1138
   PubMed Web of Science ®Google Scholar
• . Kolhe NV, Stevens PE, Crowe AV, Lipkin GW, Harrison DA. Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult, general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care. 2008;12( suppl 1):S2
   PubMedGoogle Scholar
• . Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure. A controlled trial. Nephron. 1976;17(1):51–58
   PubMed Web of Science ®Google Scholar
• . Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15(2):90–96
   PubMed Web of Science ®Google Scholar
• . Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12(12):2592–2596
   PubMed Web of Science ®Google Scholar
• . Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004;44(3):402–409
   PubMed Web of Science ®Google Scholar
• . Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288(20):2547–2553
   PubMed Web of Science ®Google Scholar
• . Uchino S, Bellomo R, Morimatsu H, ; Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med. 2005;33(9):1961–1967
   PubMed Web of Science ®Google Scholar
• . Bagshaw SM, Gibney RT, McAlister FA, Bellomo R. The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury. Trials. 11:50
   PubMed Web of Science ®Google Scholar
• . Karajala V, Mansour W, Kellum JA. Diuretics in acute kidney injury. Minerva Anestesiol. 2009;75(5):251–257
   PubMed Web of Science ®Google Scholar
• . Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes? Crit Care. 2001;5(6):294–298
   PubMed Web of Science ®Google Scholar
• . McDonald RH Jr, Goldberg LI, McNay JL, Tuttle EP Jr. Effect of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest. 1964;43:1116–1124
   PubMed Web of Science ®Google Scholar
• . Hoogenberg K, Smit AJ, Girbes AR. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med. 1998;26(2):260–265
   PubMed Web of Science ®Google Scholar
• . Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356(9248):2139–2143
   PubMed Web of Science ®Google Scholar
• . Lauschke A, Teichgraber UK, Frei U, Eckardt KU. ‘Low-dose’ dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69(9):1669–1674
   PubMed Web of Science ®Google Scholar
• . Dunning J, Khasati N, Barnard J. Low dose (renal dose) dopamine in the critically ill patient. Interact Cardiovasc Thorac Surg. 2004;3(1):114–117
   PubMedGoogle Scholar
• . Cronin RE, Erickson AM, de Torrente A, McDonald KM, Schrier RW. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int. 1978;14(2):187–190
   PubMed Web of Science ®Google Scholar
• . Anderson WP, Korner PI, Selig SE. Mechanisms involved in the renal responses to intravenous and renal artery infusions of noradrenaline in conscious dogs. J Physiol. 1981;321:21–30
   PubMed Web of Science ®Google Scholar
• . Zhang H, Smail N, Cabral A, Rogiers P, Vincent JL. Effects of norepinephrine on regional blood flow and oxygen extraction capabilities during endotoxic shock. Am J Respir Crit Care Med. 1997;155(6):1965–1971
   PubMed Web of Science ®Google Scholar
• . Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med. 1999;159(4 pt 1):1186–1192
   PubMed Web of Science ®Google Scholar
• . Redl-Wenzl EM, Armbruster C, Edelmann G, . The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med. 1993;19(3):151–154
   PubMed Web of Science ®Google Scholar
• . Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest. 1993;103(6):1826–1831
   PubMed Web of Science ®Google Scholar
• . den Ouden DT, Meinders AE. Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review. Neth J Med. 2005;63(1):4–13
   PubMed Web of Science ®Google Scholar
• . Russell JA, Walley KR, Singer J, . Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877–887
   PubMed Web of Science ®Google Scholar
• . Bellomo R, Wan L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med. 2008;36( 4 suppl):S179–S186
   PubMed Web of Science ®Google Scholar
• . Moreau R, Lebrec D. Acute kidney injury: new concepts. Hepatorenal syndrome: the role of vasopressors. Nephron Physiol. 2008;109(4):73–79
   Google Scholar
• . Lameire N, Van Biesen W, Vanholder R. The rise of prevalence and the fall of mortality of patients with acute renal failure: what the analysis of two databases does and does not tell us. J Am Soc Nephrol. 2006;17(4):923–925
   PubMed Web of Science ®Google Scholar
• . Uehlinger DE, Jakob SM, Ferrari P, . Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant. 2005;20(8):1630–1637
   PubMed Web of Science ®Google Scholar
• . Vinsonneau C, Camus C, Combes A, . Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368(9533):379–385
   PubMed Web of Science ®Google Scholar
• . Lins RL, Elseviers MM, Van der Niepen P, ; SHARF investigators. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant. 2009;24(2):512–518
   PubMed Web of Science ®Google Scholar
• . Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346(5):305–310
   PubMed Web of Science ®Google Scholar
• . Ronco C, Bellomo R, Homel P, . Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356(9223):26–30
   PubMed Web of Science ®Google Scholar
• . Saudan P, Niederberger M, De Seigneux S, . Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70(7):1312–1317
   PubMed Web of Science ®Google Scholar
• . Palevsky PM, Zhang JH, O'Connor TZ, . Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20
   PubMed Web of Science ®Google Scholar
• . Bellomo R, Cass A, Cole L, . Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627–1638
   PubMed Web of Science ®Google Scholar
• . Humes HD, Fissell WH, Weitzel WF. The bioartificial kidney in the treatment of acute renal failure. Kidney Int Suppl. 2002(80):121–125
   Google Scholar
• . Humes HD, Fissell WH, Weitzel WF, . Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis. 2002;39(5):1078–1087
   PubMed Web of Science ®Google Scholar
• . Fissell WH, Lou L, Abrishami S, Buffington DA, Humes HD. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol. 2003;14(2):454–461
   PubMed Web of Science ®Google Scholar
• . Fissell WH, Dyke DB, Weitzel WF, . Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals. Blood Purif. 2002;20(1):55–60
   PubMed Web of Science ®Google Scholar
• . Humes HD, Weitzel WF, Bartlett RH, . Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004;66(4):1578–1588
   PubMed Web of Science ®Google Scholar
• . Tumlin J, Wali R, Williams W, . Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol. 2008;19(5):1034–1040
   PubMed Web of Science ®Google Scholar
• . Ding F, Humes HD. The bioartificial kidney and bioengineered membranes in acute kidney injury. Nephron Exp Nephrol. 2008;109(4):e118–e122
   Google Scholar
• . Ronco C, Brendolan A, Lonnemann G, . A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med. 2002;30(6):1250–1255
   PubMed Web of Science ®Google Scholar
• . Vincent JL, Laterre PF, Cohen J, . A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock. 2005;23(5):400–405
   PubMed Web of Science ®Google Scholar
• . Uriu K, Osajima A, Hiroshige K, . Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis. 2002;39(5):937–947
   PubMed Web of Science ®Google Scholar
• . Cantaluppi V, Assenzio B, Pasero D, . Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med. 2008;34(9):1638–1645
   PubMed Web of Science ®Google Scholar
• . Bellomo R, Honore PM, Matson J, Ronco C, Winchester J. Extra-corporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs. 2005;28(5):450–458
   PubMed Web of Science ®Google Scholar
• . Lin F, Cordes K, Li L, . Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol. 2003;14(5):1188–1199
   PubMed Web of Science ®Google Scholar
• . Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003;112(1):42–49
   PubMed Web of Science ®Google Scholar
• . Chen J, Park HC, Addabbo F, . Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. Kidney Int. 2008;74(7):879–889
   PubMed Web of Science ®Google Scholar
• . Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest. 2005;115(7):1756–1764
   PubMed Web of Science ®Google Scholar
• . Duffield JS, Park KM, Hsiao LL, . Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005;115(7):1743–1755
   PubMed Web of Science ®Google Scholar
• . Yokoo T, Kawamura T, Kobayashi E. Stem cells for kidney repair: useful tool for acute renal failure? Kidney Int. 2008;74(7):847–849
   PubMed Web of Science ®Google Scholar
• . Takahashi K, Tanabe K, Ohnuki M, . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872
   PubMed Web of Science ®Google Scholar